Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Abbott Demonstrates End to End Laboratory Solutions

By LabMedica International staff writers
Posted on 31 Jul 2024

Abbott (Abbott Park, IL, USA) is returning to the ADLM Clinical Lab Expo (formerly AACC) in 2024 with new product launches, workshops, and live demonstrations at the show. More...

Abbott’s next-generation Alinity systems are taking center stage at ADLM 2024. The Alinity family is harmonized across key laboratory disciplines, streamlining critical interactions between individuals, systems, and information, and enabling labs to redefine performance. Abbott is demonstrating the Alinity ci-series of integrated clinical chemistry & immunoassay systems offering powerful integration across clinical chemistry and immunoassay. These systems can easily scale, combining up to four modules in multiple configurations to meet any laboratory's needs and maximize its operational efficiency. The Alinity c compact clinical chemistry system maximizes testing throughput with high-quality assays to deliver efficient and accurate performance. The Alinity I compact immunoassay system utilizes proven CHEMIFLEX chemiluminescent detection technology to provide greater confidence in results.

Abbott is also highlighting the Alinity h-series integrated hematology systems which deliver simplified workflows through an innovative design to streamline the hematology laboratory. The Alinity hq compact hematology system enables laboratories to run at maximum efficiency while the Alinity hs compact slidemaker stainer system for an automated workflow delivers consistency. Visitors to Abbott’s booth at ADLM 2024 can also experience the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer with high-quality assays that delivers the next level of flexibility and efficiency to molecular labs. Also featuring at the show is Abbott’s award-winning i-STAT Alinity point-of-care system designed to be easy, accurate and connected, providing results in minutes and integrating diagnostic patient-testing directly into the clinical-care pathway.

Additionally, a Scientific Industry Workshop from Abbott led by an expert will focus on analytical and clinical aspects across high and low hs-cardiac troponin results, while covering factors that may lead to potential misdiagnosis of myocardial infarction. Abbott’s MED Talks and LAB Voice sessions will be 20-30 minute presentations covering a wide range of key topics impacting labs, physicians, and the healthcare space today. The presentations will offer attendees emerging details on research, findings, and outcomes.

Related Links:
Abbott


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.